Coil Embolization Risks Outweigh Aneurysm Rupture Rate – NICE Committee
This article was originally published in The Gray Sheet
Executive Summary
The risks associated with coil embolization of unruptured intracranial aneurysms may exceed the annual rate of intracranial aneurysm rupture, according to UK's National Institute for Clinical Excellence
You may also be interested in...
Neurovascular, Vascular Embolization Devices Shifting To Class II
FDA is adding vascular devices to its proposed recategorization of neurovascular embolization devices from Class III to Class II with special controls
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.